Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis

Strategies for identifying patients early before cancers have spread are critical to contain the estimated 42% increase in costs over the next decade. Increased uptake of active surveillance would also lead to substantial cost-savings in the management of low-risk prostate cancer.